載入...
Proton pump inhibitors may hinder hypophosphatemic effect of lanthanum carbonate, but not of ferric citrate hydrate or sucroferric oxyhydroxide, in hemodialysis patients
Because end-stage renal disease patients undergoing hemodialysis frequently take acid suppressants for the treatment or prevention of gastrointestinal diseases, it is important to clarify the drug-interactions between acid suppressants and phosphate binders on the control of serum phosphate levels....
Na minha lista:
| 發表在: | Ren Fail |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7472469/ https://ncbi.nlm.nih.gov/pubmed/32779954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0886022X.2020.1803085 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|